Get the Stockscreener App
3.56
1.39%
-0.05
Pre-market:
3.27
-0.29
-8.15%
Verrica Pharmaceuticals Inc stock is traded at $3.56, with a volume of 48,088.
It is down -1.39% in the last 24 hours and down -23.77% over the past month.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
See More
Previous Close:
$3.61
Open:
$3.7
24h Volume:
48,088
Relative Volume:
0.18
Market Cap:
$33.63M
Revenue:
$5.12M
Net Income/Loss:
$-67.00M
P/E Ratio:
-2.4218
EPS:
-1.47
Net Cash Flow:
$-38.94M
1W Performance:
-5.32%
1M Performance:
-23.77%
6M Performance:
-24.09%
1Y Performance:
-76.73%
1-Day Range:
$3.51
$3.81
1-Week Range:
$3.43
$3.81
52-Week Range:
$3.43
$15.35
Verrica Pharmaceuticals Inc Stock (VRCA) Company Profile
Name
Verrica Pharmaceuticals Inc
Sector
Industry
Phone
484-453-3300
Address
10 NORTH HIGH STREET, WEST CHESTER, PA
Compare VRCA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VRCA
Verrica Pharmaceuticals Inc
|
3.56 | 34.10M | 5.12M | -67.00M | -38.94M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Verrica Pharmaceuticals Inc Stock (VRCA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-06-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Nov-05-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jul-25-23 | Upgrade | Needham | Hold → Buy |
| Mar-22-23 | Initiated | Jefferies | Buy |
| Feb-13-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| May-25-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-14-21 | Initiated | RBC Capital Mkts | Outperform |
| Dec-24-20 | Reiterated | H.C. Wainwright | Buy |
| Jul-15-20 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-30-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-24-20 | Initiated | Northland Capital | Outperform |
| Mar-24-20 | Initiated | Needham | Buy |
| Feb-21-19 | Initiated | H.C. Wainwright | Buy |
View All
Verrica Pharmaceuticals Inc Stock (VRCA) Latest News
How Verrica Pharmaceuticals Inc. stock valuations compare to rivalsMarket Sentiment Report & Weekly Sector Rotation Insights - newser.com
What valuation multiples suggest for Verrica Pharmaceuticals Inc. stockOptions Play & Daily Profit Focused Stock Screening - newser.com
Can Verrica Pharmaceuticals Inc. stock hit analyst price targetsMarket Movement Recap & Daily Profit Focused Stock Screening - newser.com
Can Verrica Pharmaceuticals Inc. stock deliver sustainable ROE2025 EndofYear Setup & AI Driven Stock Movement Reports - newser.com
How Verrica Pharmaceuticals Inc. (1NE) stock performs during market turbulenceProduct Launch & Reliable Price Action Trade Plans - newser.com
What technical signals suggest for Verrica Pharmaceuticals Inc. stockWeekly Trade Recap & Fast Gain Swing Alerts - newser.com
Live market analysis of Verrica Pharmaceuticals Inc.July 2025 Fed Impact & Consistent Profit Alerts - newser.com
Is Verrica Pharmaceuticals Inc. (1NE) stock positioned for secular growthQuarterly Market Summary & Weekly Chart Analysis and Trade Guides - newser.com
How to use Fibonacci retracement on Verrica Pharmaceuticals Inc.July 2025 Summary & Daily Price Action Insights - newser.com
Can trapped investors hope for a rebound in Verrica Pharmaceuticals Inc.Market Performance Report & Precise Buy Zone Tips - newser.com
Why analysts recommend Verrica Pharmaceuticals Inc. (1NE) stock2025 Technical Patterns & Real-Time Volume Analysis Alerts - newser.com
Is Verrica Pharmaceuticals Inc. (1NE) stock a safe buy pre earningsJuly 2025 Breakouts & AI Optimized Trade Strategies - newser.com
Is Verrica Pharmaceuticals Inc. stock a smart buy before Fed meetingMarket Trend Report & Smart Swing Trading Alerts - newser.com
Will Verrica Pharmaceuticals Inc. (1NE) stock justify high valuationJuly 2025 Drop Watch & Capital Efficient Trade Techniques - newser.com
What Fibonacci levels say about Verrica Pharmaceuticals Inc. reboundWeekly Investment Recap & Free AI Powered Buy and Sell Recommendations - newser.com
Applying chart zones and confluence areas to Verrica Pharmaceuticals Inc.2025 Top Gainers & AI Enhanced Trading Alerts - newser.com
Why Verrica Pharmaceuticals Inc. stock is favored by pension fundsDollar Strength & Safe Swing Trade Setup Alerts - newser.com
Published on: 2025-11-02 22:31:17 - newser.com
How sentiment analysis helps forecast Verrica Pharmaceuticals Inc.Analyst Upgrade & Expert Curated Trade Setups - newser.com
How Verrica Pharmaceuticals Inc. stock reacts to Fed rate cutsWeekly Trend Recap & Fast Entry Momentum Alerts - newser.com
What drives Verrica Pharmaceuticals Inc 1NE stock priceAnalyst Upgrades & Rapid Capital Growth - earlytimes.in
Published on: 2025-11-02 03:32:08 - newser.com
Will Verrica Pharmaceuticals Inc. (1NE) stock see insider accumulationWeekly Investment Report & Entry Point Confirmation Signals - newser.com
Why analysts raise outlook for Verrica Pharmaceuticals Inc. (1NE) stock2025 Biggest Moves & Real-Time Volume Triggers - newser.com
Short interest data insights for Verrica Pharmaceuticals Inc.Portfolio Return Summary & AI Powered Trade Plan Recommendations - newser.com
Verrica Pharmaceuticals Gains CHMP Support for YCANTH® Marketing Application in Europe - MSN
Verrica Pharmaceuticals Inc expected to post a loss of 67 cents a shareEarnings Preview - TradingView
Why Verrica Pharmaceuticals Inc. (1NE) stock remains top ratedJuly 2025 Sector Moves & Short-Term Swing Trade Alerts - newser.com
Published on: 2025-10-31 05:57:51 - newser.com
Candlestick signals on Verrica Pharmaceuticals Inc. stock todayJuly 2025 Highlights & AI Driven Price Predictions - newser.com
Published on: 2025-10-31 05:19:25 - newser.com
Verrica Pharmaceuticals Inc Stock (VRCA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):